Treatment of DU145 and PC3 prostate cancer cell lines with IL8 siRNA led to cell cycle arrest, increased apoptosis, and enhanced chemotherapeutic efficacy [54]. The gene discussed is CXCL8; the disease is prostate carcinoma.